AG
ARNA

Aperio Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Aperio Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.17M Buy
15,210
+1,888
+14% +$142K ﹤0.01% 1511
2020
Q3 		$996K Buy
13,322
+2,363
+22% +$158K ﹤0.01% 1443
2020
Q2 		$690K Buy
10,959
+329
+3% +$18.1K ﹤0.01% 1600
2020
Q1 		$446K Buy
10,630
+2,713
+34% +$124K ﹤0.01% 1714
2019
Q4 		$360K Sell
7,917
-2,653
-25% -$125K ﹤0.01% 1983
2019
Q3 		$484K Sell
10,570
-1,437
-12% -$80.8K ﹤0.01% 1773
2019
Q2 		$704K Buy
12,007
+4,426
+58% +$229K ﹤0.01% 1594
2019
Q1 		$340K Buy
7,581
+710
+10% +$32.6K ﹤0.01% 1950
2018
Q4 		$268K Buy
+6,871
New +$270K ﹤0.01% 1994
2017
Q2 		– Sell
-1,740
Closed -$25K – 2229
2017
Q1 		$25K Sell
1,740
-243
-12% -$3.6K ﹤0.01% 2137
2016
Q4 		$28K Sell
1,983
-3,937
-67% -$61K ﹤0.01% 2113
2016
Q3 		$104K Sell
5,920
-1,854
-24% -$30.7K ﹤0.01% 2022
2016
Q2 		$133K Sell
7,774
-49
-0.6% -$876 ﹤0.01% 1942
2016
Q1 		$154K Buy
7,823
+1,695
+28% +$27.2K ﹤0.01% 1921
2015
Q4 		$116K Buy
6,128
+351
+6% +$7.16K ﹤0.01% 1911
2015
Q3 		$110K Buy
5,777
+779
+16% +$26.5K ﹤0.01% 1854
2015
Q2 		$232K Buy
4,998
+23
+0.5% +$998 ﹤0.01% 1780
2015
Q1 		$217K Buy
4,975
+42
+0.9% +$1.95K ﹤0.01% 1781
2014
Q4 		$171K Buy
4,933
+35
+0.7% +$1.42K ﹤0.01% 1778
2014
Q3 		$205K Buy
4,898
+31
+0.6% +$1.38K ﹤0.01% 1590
2014
Q2 		$285K Sell
4,867
-190
-4% -$12K ﹤0.01% 1423
2014
Q1 		$319K Buy
+5,057
New +$336K ﹤0.01% 1581
2013
Q4 		– Sell
-4,934
Closed -$258K – 1589
2013
Q3 		$260K Sell
4,934
-197
-4% -$13.2K 0.01% 1504
2013
Q2 		$395K Buy
+5,131
New +$419K 0.01% 1135

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aperio Group's ARNA Position: Q4 2020 in Review

Aperio Group increased its Arena Pharmaceuticals Inc (ARNA) stake by 14% in Q4 2020, buying an estimated $142K and bringing the position to 15,210 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Aperio Group first reported a position in ARNA in Q2 2013 and has held it in 24 quarters since. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Aperio Group held 15,210 shares of Arena Pharmaceuticals Inc worth $1.17M as of Q4 2020.
  • Aperio Group bought 1,888 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $142K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1511 holding.
  • Aperio Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 24 quarters since.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.